BABA vs BALY

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

BALY exhibits severe financial distress with a Piotroski F-Score of just 2/9, indicating weak fundamental health. The company is unprofitable with a negative ROE of -115.63%, a deeply negative forward P/E of -8.25, and a profit margin of -17.41%, signaling ongoing earnings deterioration. Despite a low Price/Sales ratio of 0.33 suggesting possible value, extreme leverage (Debt/Equity: 10.85) and poor earnings predictability—evidenced by an average earnings surprise of -149.99% over the last four quarters—undermine any valuation appeal. Technical trend and insider sentiment are neutral to bearish, reinforcing a high-risk profile.